Caring for patients and managing rare disease studies requires a very different approach. Experience informs how we support and manage rare disease studies by first understanding the patient and ensuring an approach that is continually focused on reducing patient burden.
A Lean and Dedicated Team
PAREXEL has Medical and Scientific Therapeutic Area Teams providing a single point of contact for clients to more quickly access our comprehensive worldwide expertise, aligning PAREXEL’s leading medical, therapeutic area, regulatory and clinical operations experts with their counterparts at biopharmaceutical companies.
Robust and Detailed Strategy for Patient Recruitment and Retention
PAREXEL’s in-house Patient Recruitment and Strategy Group (PRSG) is a full-service group that understands the importance of working closely with patient advocacy groups to learn everything they can about the disease and its effect on daily lives, while also leveraging them to find patients.
Regulatory Advice at Every Step
We have 700+ regulatory consultants on staff, of which more than 50 have held positions at regulatory authorities across the world. They are ready to advise you on your strategies for product development, compliance, submissions and more. Our regulatory experts work closely with our clinical and operational teams for an integrated approach, informing your studies every step of the way.